Left Atrial Appendage Occlusion Using the Amplatzer Amulet Device in High-Risk Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Intervention: A Randomized Pilot Study
Open Access
- 9 October 2025
- journal article
- Published by Elsevier in Structural Heart
- Vol. 9 (12) , 100735
Abstract
No abstract availableKeywords
Funding Information
- Abbott Pharmaceuticals
- Foundation for Cardiovascular Research
This publication has 53 references indexed in Scilit:
- Comparison of fluoroscopy and transesophageal echocardiogram for intra-procedure device surveillance assessment during implantation of WatchmanInternational Journal of Cardiology, 2021
- Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial FibrillationJACC, 2020
- Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve ReplacementJACC, 2018
- 5-Year Outcomes After Left Atrial Appendage ClosureJACC, 2017
- Feasibility of LAA Closure for Left Atrial Thrombus in Patients With Aortic Stenosis and AFJACC, 2016
- Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2016
- Incidence, Predictors, and Prognostic Impact of Late Bleeding Complications After Transcatheter Aortic Valve ReplacementJACC, 2014
- Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial FibrillationJAMA, 2014
- Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin TherapyJACC, 2014
- Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin TherapyJACC: Cardiovascular Interventions, 2009